SEARCH:   Advanced

Blood, 1 December 2004, Vol. 104, No. 12, pp. 3437-3444. Prepublished online as a Blood First Edition Paper on August 10, 2004; DOI 10.1182/blood-2004-06-2234. This Article Full Text (PDF) All Versions of this Article: 2004-06-2234v1 104/12/3437    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Cook, W. D Articles by Adams, J. M Search for Related Content PubMed PubMed Citation Articles by Cook, W. D Articles by Adams, J. M Social Bookmarking                   What's this?  Previous Article  |  Next Article  Submitted June 14, 2004 Accepted July 15, 2004 PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA-binding domain Wendy D Cook*, Benjamin J McCaw, Christopher D Herring, Deborah L John, Simon J Foote, Stephen L Nutt, and Jerry M Adams Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; Dept. of Surgery, University of Melbourne, Parkville, Victoria, Australia; Monash Institute of Reproduction and Development, Clayton, Victoria, Australia Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia Dept. of Surgery, University of Melbourne, Parkville, Victoria, Australia * Corresponding author; email: Wendy.Cook{at}med.monash.edu.au. In most myeloid leukemias induced in mice by -radiation, one copy of chromosome 2 has suffered a deletion. To search for a potential tumor suppressor gene in that region, we have delineated the deletions in a panel of these tumors. A commonly deleted region of 2 Mbp includes the gene encoding the PU.1 transcription factor, a powerful inducer of granulocytic/monocytic differentiation. Significantly, in 87% of these tumors the remaining PU.1 allele exhibited point mutations in the PU.1 DNA-binding domain. Surprisingly, 86% of these mutations altered a single CpG, implicating deamination of deoxycytidine, a common mutational mechanism, as the origin of this lesion. The hot spot resides in the codon for a contact residue essential for DNA-binding by PU.1. In keeping with a tumor suppressor role for PU.1, enforced expression of wild-type PU.1 in the pro-myelocytic leukemia cells inhibited their clonogenic growth, induced monocytic differentiation and elicited apoptosis. The mutant PU.1 found in tumors retained only minimal growth suppressive function. The results suggest that PU.1 normally suppresses development of myeloid leukemia by promoting differentiation, and that the combination of gene deletion and a point mutation that impairs its ability to bind DNA is particularly leukemogenic. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: A. K. Ebralidze, F. C. Guibal, U. Steidl, P. Zhang, S. Lee, B. Bartholdy, M. A. Jorda, V. Petkova, F. Rosenbauer, G. Huang, et al. PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element Genes & Dev., August 1, 2008; 22(15): 2085 - 2092. [Abstract] [Full Text] [PDF] M. Papetti and A. I. Skoultchi Reprogramming Leukemia Cells to Terminal Differentiation and Growth Arrest by RNA Interference of PU.1 Mol. Cancer Res., October 1, 2007; 5(10): 1053 - 1062. [Abstract] [Full Text] [PDF] M Jawad, G Giotopoulos, C Cole, and M Plumb Target cell frequency is a genetically determined risk factor in radiation leukaemogenesis Br. J. Radiol., September 1, 2007; 80(Special_Issue_1): S56 - S62. [Abstract] [Full Text] [PDF] H. Tatetsu, S. Ueno, H. Hata, Y. Yamada, M. Takeya, H. Mitsuya, D. G. Tenen, and Y. Okuno Down-regulation of PU.1 by Methylation of Distal Regulatory Elements and the Promoter Is Required for Myeloma Cell Growth Cancer Res., June 1, 2007; 67(11): 5328 - 5336. [Abstract] [Full Text] [PDF] C. Langebrake, K. Gunther, J. Lauber, and D. Reinhardt Preanalytical mRNA Stabilization of Whole Bone Marrow Samples Clin. Chem., April 1, 2007; 53(4): 587 - 593. [Abstract] [Full Text] [PDF] P. Rimmele, O. Kosmider, P. Mayeux, F. Moreau-Gachelin, and C. Guillouf Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation Blood, April 1, 2007; 109(7): 3007 - 3014. [Abstract] [Full Text] [PDF] W. Huang, E. Horvath, and E. A. Eklund PU.1, Interferon Regulatory Factor (IRF) 2, and the Interferon Consensus Sequence-binding Protein (ICSBP/IRF8) Cooperate to Activate NF1 Transcription in Differentiating Myeloid Cells J. Biol. Chem., March 2, 2007; 282(9): 6629 - 6643. [Abstract] [Full Text] [PDF] M. J. Walter, R. E. Ries, J. R. Armstrong, J. S. Park, E. R. Mardis, and T. J. Ley Expression of a bcr-1 isoform of RAR{alpha}-PML does not affect the penetrance of acute promyelocytic leukemia or the acquisition of an interstitial deletion on mouse chromosome 2 Blood, February 1, 2007; 109(3): 1237 - 1240. [Abstract] [Full Text] [PDF] C. Guillouf, I. Gallais, and F. Moreau-Gachelin Spi-1/PU.1 Oncoprotein Affects Splicing Decisions in a Promoter Binding-dependent Manner J. Biol. Chem., July 14, 2006; 281(28): 19145 - 19155. [Abstract] [Full Text] [PDF] W. Cook Is PU.1 pivotal to APL? Blood, April 15, 2006; 107(8): 3017 - 3018. [Full Text] [PDF] B. U. Mueller, T. Pabst, J. Fos, V. Petkovic, M. F. Fey, N. Asou, U. Buergi, and D. G. Tenen ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression Blood, April 15, 2006; 107(8): 3330 - 3338. [Abstract] [Full Text] [PDF] D. Metcalf, A. Dakic, S. Mifsud, L. Di Rago, L. Wu, and S. Nutt Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia PNAS, January 31, 2006; 103(5): 1486 - 1491. [Abstract] [Full Text] [PDF] Y. Du, S. E. Spence, N. A. Jenkins, and N. G. Copeland Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis Blood, October 1, 2005; 106(7): 2498 - 2505. [Abstract] [Full Text] [PDF] F. Rosenbauer, S. Koschmieder, U. Steidl, and D. G. Tenen Effect of transcription-factor concentrations on leukemic stem cells Blood, September 1, 2005; 106(5): 1519 - 1524. [Abstract] [Full Text] [PDF] M. J. Walter, J. S. Park, R. E. Ries, S. K. M. Lau, M. McLellan, S. Jaeger, R. K. Wilson, E. R. Mardis, and T. J. Ley Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RAR{alpha} PNAS, August 30, 2005; 102(35): 12513 - 12518. [Abstract] [Full Text] [PDF] A. Dakic, D. Metcalf, L. Di Rago, S. Mifsud, L. Wu, and S. L. Nutt PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis J. Exp. Med., May 2, 2005; 201(9): 1487 - 1502. [Abstract] [Full Text] [PDF] S. L. Nutt, D. Metcalf, A. D'Amico, M. Polli, and L. Wu Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors J. Exp. Med., January 18, 2005; 201(2): 221 - 231. [Abstract] [Full Text] [PDF]

	Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020